Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma

Abstract Background The optimal treatment strategy for patients with borderline resectable (cT3br) esophageal squamous cell carcinoma (ESCC) remains unclear. Thus, the aim of this study was to compare the perioperative outcomes and prognoses between neoadjuvant chemotherapy combined with immunothera...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun-Peng Lin, Feng-Nian Zhuang, Wei-Jie Chen, Zhou Lin, Yu-Jie Chen, Xiao-Feng Chen, Hui Lin, Hao He, Peiyuan Wang, Hang Zhou, Wen-Wei Wei, Peng-Qiang Gao, Shuo-Yan Liu, Feng Wang
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Journal of Translational Medicine
Subjects:
Borderline resectable esophageal squamous cell carcinoma
Neoadjuvant immunotherapy
Neoadjuvant chemoradiotherapy
Perioperative outcomes
Survival
Online Access:https://doi.org/10.1186/s12967-025-06672-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12967-025-06672-3

Similar Items